{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:45:18Z","timestamp":1790163918195,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bpobgyn.2025.102681","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T23:05:35Z","timestamp":1761433535000},"page":"102681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinical management in FNAIT \u2013 navigating a complicated landscape"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3250-0750","authenticated-orcid":false,"given":"Heidi","family":"Tiller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Therese","family":"Ahlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bpobgyn.2025.102681_bib1","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood.V92.7.2280","article-title":"The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening","volume":"92","author":"Williamson","year":"1998","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bpobgyn.2025.102681_bib2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1537-2995.2005.00645.x","article-title":"Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a","volume":"45","author":"Turner","year":"2005","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102681_bib3","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2006-08-040121","article-title":"A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia","volume":"110","author":"Kjeldsen-Kragh","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102681_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/voxs.12098","article-title":"Detection of clinically relevant platelet antibodies in the Asian population","volume":"9","author":"Wu","year":"2014","journal-title":"ISBT Sci Ser"},{"issue":"12","key":"10.1016\/j.bpobgyn.2025.102681_bib5","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1016\/S2352-3026(23)00271-5","article-title":"Natural history of human platelet antigen 1a-alloimmunised pregnancies: a prospective observational cohort study","volume":"10","author":"de Vos","year":"2023","journal-title":"The Lancet Haematology"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102681_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1471-0528.2010.02657.x","article-title":"Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review","volume":"117","author":"Kamphuis","year":"2010","journal-title":"Bjog"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102681_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002490","article-title":"Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry","volume":"3","author":"Tiller","year":"2013","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102681_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/trf.13274","article-title":"Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage","volume":"56","author":"Delbos","year":"2016","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.bpobgyn.2025.102681_bib9","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/(SICI)1097-0223(199612)16:12<1152::AID-PD8>3.0.CO;2-J","article-title":"Severe fetomaternal alloimmune thrombocytopenia presenting with fetal hydrocephalus","volume":"16","author":"Murphy","year":"1996","journal-title":"Prenat Diagn"},{"issue":"8710","key":"10.1016\/j.bpobgyn.2025.102681_bib10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0140-6736(90)91842-X","article-title":"Very early intracranial haemorrhage in alloimmune fetal thrombocytopenia","volume":"336","author":"Giovangrandi","year":"1990","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102681_bib11","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/trf.13550","article-title":"Severe bleeding complications other than intracranial hemorrhage in neonatal alloimmune thrombocytopenia: a case series and review of the literature","volume":"56","author":"Winkelhorst","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.bpobgyn.2025.102681_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2023.104168","article-title":"What's with the boys? Lower birth weight in boys from HPA-1a alloimmunized pregnancies - new insights from a large prospective screening study in Poland","volume":"160","author":"Coucheron","year":"2023","journal-title":"J Reprod Immunol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102681_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0412.2011.01269.x","article-title":"Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys","volume":"91","author":"Tiller","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102681_bib14","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/aogs.14421","article-title":"Maternal alloimmune antibodies against HPA and HLA class I antigens are associated with reduced birthweight among healthy neonates delivered by Chinese women","volume":"101","author":"Xue","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102681_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12958-017-0245-6","article-title":"Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model","volume":"15","author":"Eksteen","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2025.102681_bib16","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1537-2995.2008.01832.x","article-title":"Ultrastructural localization of glycoprotein IIIa (GPIIIa, \u03b23 integrin) on placental syncytiotrophoblast microvilli: implications for platelet alloimmunization during pregnancy","volume":"48","author":"Kumpel","year":"2008","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102681_bib17","first-page":"594","article-title":"Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programme","volume":"116","author":"Tiller","year":"2009"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102681_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bjh.15813","article-title":"Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach","volume":"185","author":"Lieberman","year":"2019","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102681_bib19","doi-asserted-by":"crossref","first-page":"e844","DOI":"10.1016\/S2352-3026(22)00243-5","article-title":"Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study","volume":"9","author":"de Vos","year":"2022","journal-title":"Lancet Haematol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102681_bib20","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1182\/blood-2010-08-302463","article-title":"Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia","volume":"117","author":"Bertrand","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102681_bib21","doi-asserted-by":"crossref","first-page":"471.e1","DOI":"10.1016\/j.ajog.2016.04.033","article-title":"Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia","volume":"215","author":"Lakkaraja","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102681_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1471-0528.2007.01244.x","article-title":"Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective","volume":"114","author":"van den Akker","year":"2007","journal-title":"Bjog"},{"issue":"11","key":"10.1016\/j.bpobgyn.2025.102681_bib23","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2016-10-739656","article-title":"Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review","volume":"129","author":"Winkelhorst","year":"2017","journal-title":"Blood"},{"issue":"2 Pt 1","key":"10.1016\/j.bpobgyn.2025.102681_bib24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0002-9378(95)90559-6","article-title":"Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis","volume":"172","author":"Paidas","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"21","key":"10.1016\/j.bpobgyn.2025.102681_bib25","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM198811243192103","article-title":"Antenatal treatment of neonatal alloimmune thrombocytopenia","volume":"319","author":"Bussel","year":"1988","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102681_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102710","article-title":"The use of IVIg in fetal and neonatal alloimmune thrombocytopenia- Principles and mechanisms","volume":"59","author":"Wabnitz","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"17","key":"10.1016\/j.bpobgyn.2025.102681_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12175492","article-title":"Pregnant women at low risk of having a child with fetal and neonatal alloimmune thrombocytopenia do not require treatment with intravenous immunoglobulin","volume":"12","author":"Kjeldsen-Kragh","year":"2023","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.bpobgyn.2025.102681_bib28","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1111\/jth.14294","article-title":"Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH","volume":"16","author":"Petermann","year":"2018","journal-title":"J Thromb Haemostasis"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102681_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.transci.2003.10.004","article-title":"Evaluation of a new flow cytometric HPA 1a screening method: a rapid and reliable tool for HPA 1a screening of blood donors and pregnant women","volume":"30","author":"Killie","year":"2004","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.bpobgyn.2025.102681_bib30","doi-asserted-by":"crossref","DOI":"10.21037\/aob.2018.09.02","article-title":"Laboratory testing for the diagnosis of immune-mediated thrombocytopenia","volume":"3","author":"Matsuhashi","year":"2018","journal-title":"Ann Blood"},{"key":"10.1016\/j.bpobgyn.2025.102681_bib31","series-title":"Report of the 19th international platelet immunology workshop of ISBT","author":"Richard","year":"2018"},{"issue":"7","key":"10.1016\/j.bpobgyn.2025.102681_bib32","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/trf.14122","article-title":"Detection and identification of platelet antibodies using a sensitive multiplex assay system-platelet antibody bead array","volume":"57","author":"Metzner","year":"2017","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102681_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102711","article-title":"Fetal and neonatal alloimmune thrombocytopenia - the Norwegian management model","volume":"59","author":"Tiller","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"7","key":"10.1016\/j.bpobgyn.2025.102681_bib34","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/trf.12671","article-title":"How do we treat fetal and neonatal alloimmune thrombocytopenia?","volume":"54","author":"Bertrand","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.bpobgyn.2025.102681_bib35","series-title":"ARG Rapport 82. Graviditetsimmunisering [Working - and Reference Gruop Report 82. Immunization in Pregnancy]","author":"Wikman","year":"2023"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102681_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2022.04.044","article-title":"Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies","volume":"227","author":"Ernstsen","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102681_bib37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1423-0410.2003.00302.x","article-title":"Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?","volume":"84","author":"Radder","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.bpobgyn.2025.102681_bib38","unstructured":"Rayment R, Brunskill SJ, Soothill PW, Roberts DJ, Bussel JB, Murphy MF. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database Syst Rev 20115):Cd004226.."},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102681_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00404-020-05618-y","article-title":"Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events","volume":"302","author":"Wienzek-Lischka","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.bpobgyn.2025.102681_bib40","article-title":"Foetale en Neonatale Allo-Immuun Trombocytopenie (FNAIT): een nieuw voorgesteld beleid. [Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): a new proposed policy in the Netherlands]","author":"Pothof","year":"2025","journal-title":"Ned Tijdschr Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102681_bib41","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ajh.27193","article-title":"Does absence of intracranial hemorrhage in the first pregnancy in fetal and neonatal alloimmune thrombocytopenia preclude occurrence in the second?","volume":"99","author":"Knightly","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bpobgyn.2025.102681_bib42","article-title":"Alloimmunisering mot trombocytt-antigener (inkl FNAIT). [alloimmunization against platelet-antigens (including FNAIT)]","author":"Tiller","year":"2020","journal-title":"Norsk gynekologisk forening Veileder i f\u00f8dselshjelp ePub"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102681_bib43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ajog.2021.04.211","article-title":"New developments in fetal and neonatal alloimmune thrombocytopenia","volume":"225","author":"Bussel","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102681_bib44","first-page":"240","article-title":"The clinical use of corticosteroids in pregnancy","volume":"22","author":"Kemp","year":"2016","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102681_bib45","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/aogs.12842","article-title":"Old tools revisited give hope - new treatment option for families with a history of severe FNAIT complications","volume":"95","author":"Tiller","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2 Pt 1","key":"10.1016\/j.bpobgyn.2025.102681_bib46","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/AOG.0b013e318242a11d","article-title":"Preimplantation genetic diagnosis for fetal neonatal alloimmune thrombocytopenia due to antihuman platelet antigen maternal antibodies","volume":"119","author":"Altarescu","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102681_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0198-8859(92)90036-M","article-title":"Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3\u22170101 and HLA-DQB1\u22170201","volume":"34","author":"L'Abb\u00e9","year":"1992","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102681_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0198-8859(90)90104-W","article-title":"HLA-DRw52a is involved in alloimmunization against PL-A1 antigen","volume":"27","author":"Valentin","year":"1990","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102681_bib49","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jmb.2007.05.025","article-title":"Crystallographic structure of the human leukocyte antigen DRA, DRB3\u22170101: models of a directional alloimmune response and autoimmunity","volume":"371","author":"Parry","year":"2007","journal-title":"J Mol Biol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2025.102681_bib50","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.4049\/jimmunol.158.7.3221","article-title":"An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding: a model for unidirectional alloimmune responses","volume":"158","author":"Wu","year":"1997","journal-title":"J Immunol"},{"issue":"16","key":"10.1016\/j.bpobgyn.2025.102681_bib51","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood-2008-09-178475","article-title":"T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3\u22170101-restricted CD4+ T cells","volume":"113","author":"Ahlen","year":"2009","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bpobgyn.2025.102681_bib52","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.humimm.2013.06.025","article-title":"Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry","volume":"74","author":"Gragert","year":"2013","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102681_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12890","article-title":"The prevalence of HPA-1a alloimmunization and the potential risk of FNAIT depend on both the DRB3\u221701:01 allele and associated DR-DQ haplotypes","volume":"92","author":"Ahlen","year":"2020","journal-title":"Scand J Immunol"},{"issue":"14","key":"10.1016\/j.bpobgyn.2025.102681_bib54","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1182\/bloodadvances.2020002137","article-title":"Fetal\/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3\u221701:01 on fetal\/neonatal outcome","volume":"4","author":"Kjeldsen-Kragh","year":"2020","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102681_bib55","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3324\/haematol.12515","article-title":"A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn","volume":"93","author":"Killie","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bpobgyn.2025.102681_bib56","unstructured":"Rayment R, Brunskill SJ, Stanworth S, Soothill PW, Roberts DJ, Murphy MF. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database Syst Rev 20051):Cd004226.."},{"issue":"7","key":"10.1016\/j.bpobgyn.2025.102681_bib57","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1471-0528.2006.00993.x","article-title":"Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia?","volume":"113","author":"van den Akker","year":"2006","journal-title":"Bjog"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102681_bib58","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjh.18173","article-title":"Anti-human platelet antigen-5b antibodies and fetal and neonatal alloimmune thrombocytopenia; incidental association or cause and effect?","volume":"198","author":"Alm","year":"2022","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102681_bib59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/vox.12725","article-title":"Maternal HPA-1a antibody level and its role in predicting the severity of Fetal\/Neonatal Alloimmune Thrombocytopenia: a systematic review","volume":"114","author":"Kj\u00e6r","year":"2019","journal-title":"Vox Sang"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102681_bib60","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/1471-0528.13343","article-title":"True risk of fetal\/neonatal alloimmune thrombocytopenia in subsequent pregnancies: a prospective observational follow-up study","volume":"123","author":"Tiller","year":"2016","journal-title":"Bjog"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102681_bib61","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/vox.13779","article-title":"Screening of pregnant women for foetal neonatal alloimmune thrombocytopenia: a cost\u2013utility analysis","volume":"120","author":"de Vos","year":"2025","journal-title":"Vox Sang"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102681_bib62","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1537-2995.2007.01208.x","article-title":"Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia","volume":"47","author":"Ghevaert","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.bpobgyn.2025.102681_bib63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.placenta.2024.10.014","article-title":"Placenta-associated biomarkers and pregnancy outcome in HPA-1a alloimmunization: a prospective cohort study","volume":"158","author":"Nedberg","year":"2024","journal-title":"Placenta"},{"issue":"7","key":"10.1016\/j.bpobgyn.2025.102681_bib64","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/j.1537-2995.2011.03480.x","article-title":"Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model","volume":"52","author":"Tiller","year":"2012","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.bpobgyn.2025.102681_bib65","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.4049\/jimmunol.1401599","article-title":"Characterization of a human platelet antigen-1a-specific monoclonal antibody derived from a B cell from a woman alloimmunized in pregnancy","volume":"194","author":"Eksteen","year":"2015","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102681_bib66","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4049\/immunohorizons.2100097","article-title":"Prevention of Fetal\/Neonatal alloimmune thrombocytopenia in mice: biochemical and cell biological characterization of isoforms of a human monoclonal antibody","volume":"6","author":"M\u00f8rtberg","year":"2022","journal-title":"Immunohorizons"},{"issue":"20","key":"10.1016\/j.bpobgyn.2025.102681_bib67","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood.2022015666","article-title":"Prophylactic administration of HPA-1a-specific antibodies prevents fetal\/neonatal alloimmune thrombocytopenia in mice","volume":"140","author":"Zhi","year":"2022","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102681_bib68","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/a-2398-9344","article-title":"A phase 1b PK\/PD study to demonstrate antigen elimination with RLYB212, a monoclonal Anti-HPA-1a antibody for FNAIT prevention","volume":"125","author":"Geisen","year":"2025","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102681_bib69","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa2314466","article-title":"Nipocalimab in early-onset severe hemolytic disease of the fetus and newborn","volume":"391","author":"Moise","year":"2024","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.bpobgyn.2025.102681_bib70","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/aogs.70031","article-title":"Heidi Tiller Improving prediction of fetal\/neonatal intracranial hemorrhage in HPA-1a alloimmunized pregnancies to guide antenatal management: An observational cohort study","volume":"104","author":"Siw Leiknes Ernstsen","year":"2025","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693425001051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693425001051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:41:01Z","timestamp":1764780061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693425001051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":70,"alternative-id":["S1521693425001051"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2025.102681","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical management in FNAIT \u2013 navigating a complicated landscape","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2025.102681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102681"}}